Désolé, cet article est seulement disponible en EN.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Présentation
Projets Transversaux
Projets
Brevets
Anciennes Équipes
CV
Maîtrise/D.E.A. (Masters) Microbiology – Basic virology , 2004. Université Paris VII – Denis Diderot, France PhD in Virology and Molecular Biology, 2008. Université Paris VI – Pierre et Marie Curie, France. Laboratory of Matteo Negroni. Postdoctoral Fellow, 2009-2012. Laboratory of Edward C. Holmes , The Pennsylvania State University, USA.
Publications
Télécharger-
2024Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion., Nat Commun 2024 Mar; 15(1): 2254.
-
2023High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1., J Virol 2023 Dec; (): e0135123.
-
2023Untargeted metagenomic sequencing identifies Toscana virus in patients with idiopathic meningitis, southern Spain, 2015 to 2019., Euro Surveill 2023 Nov; 28(45): .
-
2023TMPRSS2 is a functional receptor for human coronavirus HKU1., Nature 2023 Oct; (): .
-
2023Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants., Nat Commun 2023 Jul; 14(1): 4485.
-
2023APOBEC3F is a mutational driver of the human Monkeypox virus identified in the 2022 outbreak., J Infect Dis 2023 May; (): .
-
2023Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV-2 omicron sub-lineages., iScience 2023 Apr; 26(4): 106413.
-
2023Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies., Nat Commun 2023 Feb; 14(1): 824.
-
2023Tocilizumab treated convalescent COVID-19 patients retain the cross-neutralization potential against SARS-CoV-2 variants., iScience 2023 Feb; (): 106124.
-
2022Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5 in patients receiving monoclonal antibodies., Cell Rep Med 2022 Nov; (): 100850.
-
+Voir la liste complète de publications